This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Advantages and disadvantages Traditional topicals including water-based lotions and creams and oil-based balms and salves offer a quick onset time, no psychoactivity, and the potential to treat not only aches, pains, and inflammation, but also skin conditions like psoriasis and eczema. Clinical benefits? So what do the studies say?
However, there has not been a clinicaltrial assessing the efficacy of cannabis for migraines, at least not until now. Science Alert has announced that the first clinicaltrial for cannabis as a migraine treatment is underway. This is exciting news for individuals who suffer from this debilitating condition.
The majority of people who use the cannabinoid cannabigerol (CBG) for medical reasons find it to be helpful or very helpful in treating a variety of health conditions, according to the findings of a recent survey. No clinicaltrial was used in the compilation of the study. reported no withdrawal symptoms.
Many patients are turning to cannabis for insomnia relief, seeking its potential to improve sleep quality and duration. Insomnia is a common sleep disorder characterized by difficulty falling asleep, staying asleep, or experiencing non-restorative sleep despite having the opportunity to sleep.
CBN has made headlines and claimed shelf space as the next best cannabinoid for sleep. MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. It also, allegedly, helps with sleep (more on that below). Back to our study.
IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinicaltrial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. This Phase 1 trial is currently testing IGC-AD1 for safety.
Ohio is currently accepting petitions in an attempt to expand the list of qualifying conditions for medical cannabis. Medical cannabis is now available to residents in Ohio who meet one of 22 qualifying conditions laid out by House Bill 523. Strict Guidelines Must be Met Before Conditions Will Be Considered.
The agreement between the two companies will see Procaps making IHL-42X for Incannex’s Phase 2, Phase 3, and open-label clinicaltrials. If these trials are successful and IHL-42X is approved for the market, Procaps will also make IHL-42X for patients.
As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. improvement in good sleep.
She was upset with herself for being so careless and concerned that the condition would persist. For the next couple days, she got extra sleep to aid recovery, and for good measure took an extra dose or two of CBD. And it’s not just ringing.
As the medical community delves into the therapeutic potential of cannabis, certain health conditions have emerged as primary candidates for its prescription. THC, the psychoactive component of cannabis, has analgesic properties that can help manage chronic pain conditions, such as neuropathic pain and arthritis.
Of course, this plant is now known to be marijuana (or Type I cannabis), which is still commonly used for sleep and analgesia today. CBN has been receiving a lot of attention for its ability to induce sleep, as it’s frequently marketed as nature’s sleep aid. What can the current clinicaltrials tell us?
And it does appear to address some of the main issues that people turn to cannabis for — inflammation, pain, anxiety, sleep problems, depression, and cancer. CannMed: For what conditions do you think CBG has the most promise? It was highly rated for anxiety, pain, depression, and sleep problems.
Researchers have been investigating the use of cannabis to treat fibromyalgia’s constellation of symptoms for decades, with early clinicaltrials in the 2000s 1-4 suggesting a possible benefit of both pure THC and flower in managing the disease. It’s not a new idea. That seemed to make all the difference.
Sleep Improvement: Many PTSD sufferers experience insomnia and nightmares. Cannabis, particularly strains high in THC, can improve sleep quality and reduce the frequency of nightmares. Various clinicaltrials are investigating the effectiveness of cannabis and its components in treating PTSD symptoms.
Additionally, the ACPA reported on a clinicaltrial that suggests that inhaled cannabis may provide short-term relief from Neuropathy. When the body is defensive against trauma, this system begins to fail, resulting in physical, mental and/or neurological conditions. Analgesic/”Opiate Type Pain Relief”. Appetite Stimulant.
As if those weren’t enough, the fear of the virus alone can also wreak havoc on sleep patterns. Patients around the world are reporting a sharp increase in sleep problems, and physicians have coined the term coronasomnia to describe the phenomenon. A team of researchers is studying the coronavirus-era sleep crisis.
Post-Traumatic Stress Disorder (PTSD) is a multifaceted mental health condition triggered by experiencing or witnessing traumatic events, persistently manifesting in symptoms like flashbacks, severe anxiety, and disrupted sleep. Looking ahead, the future of medical cannabis in PTSD treatment hinges on overcoming these challenges.
Immune System and Sleep Deprivation. Overproduction or underproduction of cortisol can both cause problems with sleep (insomnia), as well as leading to a weakened response from your immune cells when they’re needed most—when you’re sick or fighting off an infection! the cavities around your nose). We Need More Research.
41% said cannabis somewhat addressed motor symptoms (43% for stiffness and 42% for tremors) 43% said cannabis somewhat addressed non-motor symptoms (46% for anxiety, 44% for sleep disorders, 44% for pain). Those who use high THC products were 7.43 times more likely to report side effects than those who use high or pure CBD products.
#image_title Families affected by Huntington’s Disease (HD) know to well that this hereditary neurodegenerative condition progressively impacts movement, cognition, and behavior, profoundly affecting both patients and their loved ones. But what truly matters is how these improvements translate into real life.
My partner, who was diagnosed with Crohn’s Disease at the age of 19, was able to improve his quality of life with cannabis by managing his nausea, poor quality sleep, gut motility, appetite, pain, and anxiety with a single substance. The more I read about it, the more I became fascinated with the chemistry and potential of cannabis.
Both IBD and IBS have a major impact on the quality of life and on the ability to do simple things such as eat, sleep, and work. Ulcerative Colitis is a condition that causes long-lasting inflammation and ulcers (sores) in the innermost lining of the individual’s large intestine and rectum. Inflammatory-based condition.
Of those states that had legalized medical marijuana, 14 currently consider Parkinson’s disease a qualifying condition for medical marijuana therapies. The most common non-motor symptoms that cannabis users were trying to treat with their cannabis use were anxiety, pain, and sleep disorders. Florida is among these states.
And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions. Others say if they use before bedtime, they can’t sleep, they stay awake all night. There’s a condition that we call GERD, gastroesophageal reflux disease.
Cannabis is an effective tool for the treatment of topical skin conditions In a recent study by undertaken by MGC Pharma, our dermatologists found that CBD is effective in providing relief for relief for dry, red, flakey, oily and acne prone skin through CBD skincare.
Living with chronic conditions such as Multiple Sclerosis (MS) is profoundly challenging and impacts various aspects of daily life. of medical marijuana as a viable treatment option for certain conditions, including Multiple Sclerosis (MS), leading to increased advocacy for uniform regulations and broader accessibility.
Both THC and CBD have demonstrated analgesic properties, making them valuable for managing chronic pain conditions such as arthritis, fibromyalgia, and cancer-related pain. Epilepsy Management: CBD, in particular, has emerged as an effective treatment for epilepsy, especially in individuals with rare and severe forms of the condition.
More and more influential medical associations support cannabis and its derivatives for pain management and other medical conditions because research has shown it to be effective. About 10% to 15% of patients attending a chronic pain clinic use cannabis as part of their pain [control] strategy," he tells WebMD.
During the four-week study, participants will use the Radicle Science platform to track consumption and effectiveness of orally ingested CBD products on well-being, quality of life, pain, sleep disturbance, and anxiety. We are delighted to have Lord Jones involved in the Radicle Sciences’ ACES study.
The outcomes and measures used throughout the trial included changes in CUD symptoms; anxiety and depressive symptoms; pain severity; and insomnia symptoms. The outcomes and measures used throughout the trial included changes in CUD symptoms; anxiety and depressive symptoms; pain severity; and insomnia symptoms.
As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. improvement in good sleep.
The results suggested that a ratio of the THC and CBD extracts was more effective than the placebo given to some patients to reduce pain and improve sleep. ” In this clinicaltrial, the efficacy of a synthetic THC compound (dronabinol) was found to improve appetite and weight gain in patients experiencing lack of appetite.
– ‘Pandemic increased demand’ – “The pandemic increased CBD demand because there obviously were stress, sleep problems, anxiety, these kind of risks,” ACI co-founder Steve Moore told AFP. That was almost a third higher than the UK trade group’s pre-pandemic 2019 projection.
(OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinicaltrial on neuropathic and post-operative pain.
Of the 248,000 scripts approved for Australians since inception of national medicinal cannabis scheme in 2016, many related to conditions for which the drug has limited evidence of efficacy, a new University of Sydney study shows. Since the beginning of the program, medicinal cannabis has been prescribed for over 140 conditions.
Medical marijuana has shown potential in treating a wide range of medical conditions, including epilepsy. Epilepsy and MMJ: A Patient’s Perspective For individuals living with epilepsy, finding an effective treatment is often a journey marked by trial and error.
While many health conditions can be treated with more traditional pharmaceuticals, plant-based products may be a safer and healthier option – or at least a safe health supplement. Getting a good night’s sleep is a crucial step in leading a healthier lifestyle, and the benefits can be felt throughout the day.
Neuropathic pain, often a chronic and debilitating condition, springs up from damage or dysfunction in the nervous system. They can help you determine the best strains, dosages, and methods of administration for your specific condition. Consult with a healthcare provider to determine if you qualify.
Usually, the diagnosis involves excluding conditions like parasitic infections, lactose intolerance tests and small intestinal bacterial overgrowth which all produce symptoms like IBS. Constant gut symptoms often lead to the development of other conditions like anxiety , depression , migraines , sleeping problems and fatigue.
This was the birth of the world’s first sleeping pill. MAOIs are important for inhibiting neurotransmitters that have been impacted by depression, thus allowing some relief from the condition. Heart Pacemaker. While this may not be a drug per se, it is still a major medical discovery that was made by accident.
Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. of prescriptions were for sleep disorders. We are aware of clinicaltrials in that space, but not strong evidence.”. The Guardian writes. Read their full article at.
Technically speaking, it’s not produced by the plant, but is rather a degradation product of delta-9-THC, often as a result of aging and storage conditions. The endocannabinoid system has been shown to help regulate many key functions such as sleep, hunger, mood, immune response, and memory. Delta-8-THC research.
Despite the companies’ submitting the required data demonstrating the “reasonable expectation of safety under the recommended conditions of use,” the FDA rejected the applications, citing the drug preclusion clause. Approved cannabinoids for medical purposes: Comparative systematic review and meta-analysis for sleep and appetite.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content